No headlines found.
Globe Newswire (Tue, 3-Sep 4:05 PM ET)
Assertio Reports Second Quarter 2024 Financial Results
Globe Newswire (Wed, 7-Aug 4:01 PM ET)
Assertio Holdings, Inc. to Report Second Quarter 2024 Financial Results on August 7, 2024
Globe Newswire (Wed, 24-Jul 4:05 PM ET)
Buxton Helmsley Issues Letter to the Board of Directors of Assertio Holdings, Inc.
Business Wire (Wed, 24-Jul 9:00 AM ET)
Assertio Holdings, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Globe Newswire (Tue, 9-Jul 4:30 PM ET)
Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults of age or older; and Zipsor, liquid-filled capsules for relief of mild to moderate pain.
Assertio Holdings trades on the NASDAQ stock market under the symbol ASRT.
As of September 18, 2024, ASRT stock price was flat at $1.30 with 524,908 million shares trading.
ASRT has a beta of 0.88, meaning it tends to be less sensitive to market movements. ASRT has a correlation of 0.01 to the broad based SPY ETF.
ASRT has a market cap of $123.94 million. This is considered a Micro Cap stock.
Last quarter Assertio Holdings reported $31 million in Revenue and $.02 earnings per share. This beat revenue expectation by $936,000 and exceeded earnings estimates by $.05.
In the last 3 years, ASRT stock traded as high as $8.01 and as low as $.73.
The top ETF exchange traded funds that ASRT belongs to (by Net Assets): VTI, VXF, PRFZ, BSVO, EES.
ASRT stock has underperformed the market in the last year with a return of -52.8%, while SPY returned +27.8%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in ASRT shares. However, ASRT has outperformed the market in the last 3 month and 2 week periods, returning +23.8% and +17.1%, while SPY returned +2.9% and +1.7%, respectively. This indicates ASRT has been having a stronger performance recently.
ASRT support price is $1.24 and resistance is $1.36 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ASRT stock will trade within this expected range on the day.